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ABSTRACT
Background Zika virus (ZIKV) has been associated with a variety of neuropathologies,
including microcephaly. We hypothesize that ZIKV genes activate host microRNAs (miRNAs)
causing dysfunctional development of human fetal brains.
Objectives/methods A bioinformatics search for miRNA genome-wide binding sites in the
prototypic ZIKV (strain MR766) was undertaken to hunt for miRNAs with significant similarities
with MCPH genetic sequences responsible for inducing MCHP in human fetal brains.
Results Six ZIKV miRNAs were found to share mutual homology with 12 MCPH genetic
sequences responsible for inducing MCPH. Noteworthy was miR-1304, which expressed
100% identity to six different MCPH genes.
Conclusions We suggest that following infection of fetal neurons ZIKV may modulate the
action of various miRNAs, and miR-1304 in particular, resulting in microcephaly.
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Zika virus (ZIKV) is of emerging public health concern.
It is a positive-sense, single-stranded RNA member of
the Spondweni serocomplex within the genus
Flavivirus, family Flaviviridae [1]. The natural transmis-
sion cycle of ZIKV predominantly involves vectors
from the Aedes genus and monkeys [2], although
ZIKV antibodies have been discovered in a number
of other animals [3,4], including rodents [5]. Humans
generally act as infrequent hosts [6], but may repre-
sent a primary amplification and reservoir species [7].
While first isolated in 1947, ZIKV was initially
described in 1952 [8].The original ZIKV isolate was
derived from a captive fevered rhesus macaque,
Macaca mulatta, that had been platform caged and
held in the canopy of Zika Forest, near Lake Victoria,
Uganda, as part of a yellow fever sentinel programme.
The macaque’s serum was inoculated intracerebrally
into mice which, after 10 days, became ill. A filterable
communicable agent was subsequently isolated from
the mice brains [9]. Dick [9] and MacNamara [10] also
established the presence of ZIKV antibodies in human
sera derived from West Nile and Bwamba provinces,
Uganda and from Nigeria respectively. Transmission
of ZIKV from A. aegypti to laboratory mice and a
monkey was established by Boorman and Porterfield
in 1956 [11], while the first report of humans infected
with ZIKV was from Nigeria in 1954, following an
outbreak of jaundice in Afikpo [12]. ZIKV causes an
acute febrile illness, symptomatically similar to
Dengue, and is characterized by mild headache,
fever, maculopapular rash, joint and back pain, and
general malaise, sometimes accompanied by conjunc-
tival hyperemia, anorexia, dizziness, diarrhea, and con-
stipation [13–17].The incubation period is between 3
and12 days and symptoms may last for 2–7 days. Only
~20% of patients infected with ZIKV exhibit any symp-
toms, and ZIKV has never been reported to cause
hemorrhagic fever or death and is often misdiagnosed
as Dengue [13–15].
The natural range of ZIKV appears to be restricted
to equatorial Africa and South-east Asia. Molecular
isolate evaluations of 43 strains of ZIKV from 9 coun-
tries indicate that the virus likely emerged in Uganda
between 1892 and 1943 [6,15] and undertook two
westward migrations, firstly in the mid-1930s and
again in 1940, and an easterly immigration during
1945. Until recently, other than occurrences in
Uganda and Nigeria, ZIKV outbreaks had been
reported only sporadically in Burkina Faso, the
Cameroon, Cape Verde Islands, Côte d’Ivoire, Gabon,
Senegal, Sierra Leone, and the Central African
Republic [7,15]. Cases and or serological evidence
place ZIKV in Pakistan, India, Bangladesh, Malaysia,
the Philippines, Thailand, Vietnam, and Indonesia [2].
In 2007 the first occurrence of ZIKV outside of its
apparent natural range was recorded on the island
of Yap, Federated States of Micronesia [13,16]. This
outbreak was initially thought to be Dengue, but
serological analyses identified RNA of ZIKV.
Subsequently, ZIKV occurrences were reported for
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French Polynesia, Easter Island, the Cook Islands, and
New Caledonia [14,15,17]; with the initiating strain
most likely being derived from South-east Asia [7].
The French Polynesian outbreak of ZIKV was remark-
able because 74 infected individuals presented with
neurological symptoms, of which 47 were later diag-
nosed with Guillain-Barré Syndrome (GBS; [18]).
In early 2015, a serious ZIKV outbreak was recorded
in Camaçari, Bahia, Brazil, [19] and it has been sug-
gested [20] that this resulted from viral transmission
from French Polynesia, as later confirmed by RT-PCR
[21].The Camaçari, Bahia ZIKV outbreak was followed
by similar illnesses in five neighbouring states, which
led the Brazilian Ministry of Health to issue a ZIKV alert
in April 2015 [22]. Similar to the French Polynesian
outbreak, patients presented with neurologic disor-
ders consistent with GBS. More troubling, however,
was the sharp increase in the number of children
being born with microcephaly [12–15,23]. In certain
instances, impacted regions registered a more than
tenfold increased occurrence; a magnitude surge that
cannot be explained by random clustering. Because
the microcephaly amplification was registered within
nine months of the ZIKV outbreak, and since materno-
fetal transmissions of other Flaviviruses are known to
occur, it has been suggested that a link may exist for
ZIKV and microcephaly [14,18]. There is mounting
evidence that ZIKV is associated with a variety of
neurological syndromes, including GBS, meningitis,
myelitis, and meningocephalitis [15]. The existence
of a link between fetal defects, microcephaly, and
ZIKV infection during pregnancy is strong [15].
Furthermore, increased CNS deformities have been
reported for newborns in French Polynesia following
their ZIKV epidemic, [18] and new reports linking
microcephaly and ZIKV have appeared [14,15].
Since the report of Brazilian ZIKV outbreaks, the
virus has migrated throughout the region and ill-
nesses have been described for most other South
and Central American countries [19]. The pandemic
has also swept into the Caribbean, with autochtho-
nous transmission in at least six island states
(Barbados, Guadeloupe, Haiti, Martinique, Puerto
Rico, and Saint Martin). The rapidity of movement of
ZIKV, and its potential association with microcephaly,
has prompted some governments of the region to go
as far as to advise women against becoming pregnant
[14]. On 1 February 2016, the World Health
Organization (WHO) announced that the ZIKV out-
break was an ‘international health emergency’; WHO
expects up to four million cases in the Americas. ZIKV
has also been imported from infected regions into the
USA, Canada, and some EU member states (Finland,
Germany, and the Netherlands).
As is the case for other viruses that pose significant
health threats to humans (e.g. Dengue and
Chikungunya), it is now evident that ZIKV can be
transmitted by the Asian tiger mosquito, Aedes albo-
pictus [17]. From a public health perspective, appre-
ciating the current and future ranges of vectors will
be critical to developing effective planning for disease
control [20]. An essential component of risk analysis
must, therefore, be changes in prevailing climate,
since climate change has been associated with range
expansion. A. albopictus is already established in Italy,
southern France, and Spain, and its range extends
along the Adriatic to Greece and thence to Bulgaria,
Romania, Russia, and Palestine. Transient occurrences
for A. albopictus have been reported in Belgium, the
Netherlands, Germany, Serbia, and Hungary. Taking
into account climate change and associated rising
temperatures, including modifications in precipitation
and vegetation, various models reveal that the distri-
bution of A. albopictus will inevitably broaden sub-
stantially across Europe and around the
Mediterranean [19–21]. Sustained drought, however,
may lessen local range in Sardinia and parts Spain.
As in Europe, the Asian tiger mosquito is also well
established in the United States, being resident in at
least 36 states, including New Jersey [22]. It has been
associated with the transmission of West Nile Virus,
eastern equine encephalitis, and La Crosse viruses
and, mimicking the models of Europe, climate-based
evaluations of its spread indicate significant range
extension [21,22]. A. albopictus could provide a vector
for the onward transmission of ZIKV across both con-
tinents. At present, no specific vaccines or treatment
for ZIKV are available and, although the possibility
exists that present flavivirus vaccine technologies
could be adapted to ZIKV [21,22], it is important to
investigate the molecular pathogenesis of the virus.
There are number of questions that remain to be
answered before an effective strategy toward a ZIKV
vaccine can be mapped out. It is still unclear how and
at what time of gestation ZIKV infects fetal brain cells,
and what types of progenitor cells are infected by the
virus. Data from Tang et al. [23] and our laboratory
suggest that human progenitor neurons are highly
permissive to ZIKV, whereas mature neurons are rela-
tively resistant to the virus ([23], and unpublished
data). Equally important is to establish whether the
virus targets specific types of progenitor neurons (i.e.
cerebral cortex, ocular neuron, or other neuronal
types) that express specific receptors, or whether the
virus infection causes global dysregulation in fetal
brain development [16]. It is also unknown if certain
genotypes of ZIKV are more neurotropic than
others [24].
We hypothesize that ZIKV infection of the fetal
brain modulates microRNAs (miRNAs) involved in reg-
ulating microcephaly genes and explore whether ZIKV
can activate intracellular pathways leading to this
condition [25]. Autosomal recessive primary microce-
phaly (MCPH) is a neurogenic mitotic disorder present





























at birth, and is characterized by non-progressive men-
tal retardation [26–28]. MCPH is the outcome of a
smaller but architecturally normal brain, with patients
exhibiting a significant decrease in size of the cerebral
cortex. The head circumference (HC) shows ≥3 stan-
dard deviations from the norm when compared to
age and sex matched controls (typical HC: [29,30]).
Twelve MCPH loci (MCPH1-MCPH12) have been
mapped that contain the following genes:
Microcephalin, WDR62; CDK5RAP2; CASC5; ASPM;
CENPJ; STIL; CEP135; CEP152; ZNF335; PHC1; and
CDK6. It is predicted that MCPH gene modulations
may lead to the disease phenotype due to a disturbed
mitotic spindle orientation, premature chromosomal
condensation, altered signaling response as a result of
damaged DNA, deranged microtubule dynamics, tran-
scriptional control, or other hidden centrosomal
mechanisms that regulate the number of neurons
produced by neuronal precursor cells [27].
In order to explore ZIKV-mediated modulations of
host genetic pathways, we hypothesized that ZIKV
genes activate numerous host miRNAs that results in
miRNA-based modifications of neuronal genetic path-
ways that share mutual homologies to MCHP genes.
miRNAs are small noncoding RNAs that act as gene
regulators. They are directly or indirectly involved in
many cellular functions owing to their ability to target
mRNAs for degradation or translational repression
[25]. Experimental evidence shows that miRNAs have
a direct role in different cellular processes, such as
immune function, apoptosis, and tumorigenesis. In a
viral infection context, miRNAs have been connected
with the interplay between host and pathogen, occu-
pying a major role in pathogenesis. While numerous
viral miRNAs from DNA viruses have been identified,
characterization of functional RNA virus-encoded
miRNAs and their potential targets is still ongoing
[31]. How cellular miRNAs are regulated and their
functions controlled during ZIKV infection are largely
unknown. miRNAs are critical regulators of gene
expression that utilize sequence complementarity to
bind to and modulate the stability or translation effi-
ciency of target mRNAs. In the case of GBV-C, a
nonpathogenic flavivirus, profound modulations of
miRNAs have been reported [32]. Accumulating data
suggest that miRNAs regulate a wide variety of mole-
cular mechanisms in host cells during viral infections
[31,32].
In the present study, we have conducted a bioin-
formatics search for miRNA genome-wide binding
sites in the prototypic ZIKV MR766 whole genome,
and discovered six miRNAs that share significant
mutual homology with the 12 MCPH genetic
sequences which may be responsible for inducing
MCPH in the developing human fetal brain. The six
miRNAs – miR-627–5, miR-4646, miR-1304, miR-6771,
miR-4528, and miR-3198 – shared high degrees of
mutual homologies to the ZIKV genome and the 12
MCPH genes (Table 1 and Figure 1). In all cases, these
miRNAs shared 100% identity at the seed sequences
(3ʹ-2–8 base pairs) and between 75–100% homologies
at the genetic level, suggesting that the genetic tar-
gets we identified most likely play a significant role in
inducing MCPH [32]. To our knowledge, this is the first
report of the comparative analyses of mutually homo-
logous miRNAs in ZIKV and MCPH genes. Our findings
will underpin further studies of miRNAs’ roles in ZIKV
replication and identify potential candidates for anti-
viral therapies against ZIKV, as well as future studies
to prevent MCPH [12–14,30].
Each of the MCPH genes listed and various func-
tions associated with each of the MCPH genes linked
to various molecular pathways that subsequently
result in MCPH, either alone or in combination with
other genetic mutations or MCPH gene modulations,
are depicted in Table 2. For example, MCPH1
(Microcephalin) is involved in chromosomal condensa-
tion, and reduced MCPH1 enhances the production of
early born neurons, which comprise deep layers (IV–
VI), and reduces late-born neurons, which produce the
thinner outer cortex layer (II–III). MCPH2 (WDR62) is
involved in cerebral cortical development, prolifera-
tion and migration of neuronal precursors, and muta-
tion in WDR62 affects its role in proliferating and
migrating neural precursors and causes severe brain
malformations. MCPH3 (CDK5RAP2) regulates
Table 1. MCPH genes, their location, and homologous miRNA.
Locus Gene Cytoband Cellular location miRNA
MCPH1 Microcephalin 8p23.1 Nucleus miR-627–5
MCPH2 WDR62 19q13.12 Nucleus/Centrosomes/Neuronal precursors/Post-mitotic neurons miR-4646
MCPH3 CDK5RAP2 9q33.2 Centrosome miR-627–5,
miR-1304
MCPH4 CASC5 15q15.1 Kinetochore miR-1304
MCPH5 ASPM 1q31.3 Pericentrosomal miR-627–5,miR-1304
MCPH6 CENPJ 13q12.12 Centrosome/neuropithelium of the frontal cortex hsa-miR-6771
MCPH7 STIL 1p33 Pericentrosomal miR-4528
MCPH8 CEP135 4q12 Centrosome miR-1304
MCPH9 CEP135 15q21.1 Centrosome miR-1304
MCPH10 ZNF335 20q13.12 Nucleus miR-1304
MCPH11 PHC1 12p13.31 Nucleus miR-3198
MCPH12 CDK6 7q21.11 Cytoplasmic/nuclear miR-1304





























microtubule function, and mutation in CDK5RAP2
reduces the progenitor pool/decreases the number
of neurons and reduces cell survival. MCPH4 (CASC5)
is vital for the spindle checkpoint of the mitotic cycle.
CASC5 underscores the role of kinetochore integrity in
the proper volumetric development of the human
brain. MCPH5 (ASPM) plays an essential role in orienta-
tion of mitotic spindles during embryonic neurogen-
esis, and ASPM mutations are known to decrease the
size of the brain by influencing the orientation of the
mitotic spindle. MCPH6 (CENPJ) controls centriole
length/microtubule function; its deletion causes an
increased incidence of multiple spindle poles, apop-
tosis and mitosis arrest. MCPH7 (STIL) is important in
apoptosis regulator/cell cycle progression; its muta-
tion in zebrafish, Danio rerio, causes an embryonic
lethal defect, and STIL knockout mice (Sil-/-) exhibit
numerous developmental abnormalities/decreased
size/defective midline of the neural tube. MCPH8
(CEP135) maintains organization/structure of the cen-
trosome, and CEP135 knockdown showed decreased
growth rate/disorganized microtubules. MCPH9
(CEP152) is involved in centriole duplication/shape to
cell/polarity/motility; conversion of glutamine into
proline disturbs potential coiled-coiled protein
domain/reduced head size. MCPH10 (ZNF335) is essen-
tial in progenitor cell division/differentiation; mutated
ZNF335 gene causes degeneration of neurons, and
knockdown of ZNF335 caused a small brain size with
an absent cortex/disrupted proliferation and differen-
tiation of neuronal cells. MCPH11 (PHC1) regulates the
cell cycle, and its mutation highlights the role of
chromatin remodeling in the pathogenesis of primary
microcephaly. MCPH12 (CDK6) controls the cell cycle
and differentiation of various cell types, and is
engaged in microtubule organization [27]. Its muta-
tion affects apical neuronal precursor cell prolifera-
tion, reduces the progenitor pool, and decreases
neuronal production. We were surprised to observe
that one particular microRNA, hsa-miR-1304, showed
100% identify at the seed sequences of six different
MCPH genes, namely MCPH 3, 4, 8, 9, 10, and 12, and
the ZIKV genome. Therefore, it would not be illogical
to hypothesize that this particular miRNA appears to
play a pivotal role in development of the cerebral
cortex of a developing fetus, and perturbation in this
miRNA may impart some kind of neurodevelopmental
error. In addition, hsa-miR-627–5 also showed a 100%
Figure 1. Locations of miRNA to ZIKV and MCPH. The upper panel illustrates the 10.79KB genomic map of ZIKV while the lower
panel presents the 12 MCPH genes involved in microcephaly primary heredity (MCPH) or autosomal recessive primary
microcephaly. Six miRNAs aligned perfectly at the seed sequences (shown in the middle panel) with the ZIKV and 12 MCPH
genomes. Of note, miR-1304 targets six out of 12 MCPH genes.
Table 2. Summary of neurological disease and behavior genes, their location, and associated role with miRNA-1304.
Gene Cytoband Function References
GABRE Xq28 Subjects with schizophrenia, major depression and bipolar disorder, migraine susceptibility [2,5]
VPS26A 10q21.1 Involved in retrograde transport of proteins from endosomes to the trans-Golgi network. [4]
DSEL 18q22.1 Associated with chromosome 18q-linked bipolar disorder, depressive disorder [1,4]
ERK 22q11.22 Plays major role in neurotrophin signaling pathway [1,3]
MAP3k14 17q21.31 Participates in an NF-kappaB-inducing signaling cascade common to receptors of the tumor-necrosis/nerve-
growth factor(TNF/NGF)
[4,6]
ITSN1 21q22.11 Required for neuroblastoma tumorigenesis and reduction leads to apoptosis [5]
NF2 22q12.2 Mutation in this gene is associated with neurofibromatosis and glioblastoma [3,4]
TTBK1 6p21.1 Induces aggregation of TAU, related for Alzheimer’s diseases risk. [1,2,5]
C20orf194 20p13 Linked with spinocerebellar ataxia [2]
DAG1 3p21.31 Associated with muscle-eye-brain diseases and glioma [2,4,6]
Notes: GABRE: Gamma-aminobutyric acid (GABA) A receptor, epsilon; VPS26A: Vacuolar protein sorting-associated protein 26A; DSEL: Dermatan sulfate
epimerase-like; ERK: Extracellular signal-regulated kinases; MAP3k14: Mitogen-activated protein kinase kinase kinase 14; ITSN1: Intersectin 1; NF2:
Neurofibromin 2; TTBK1: Tau tubulin kinase 1; C20orf194: Chromosome 20 open reading frame 194; DAG1: Dystrophin-associated glycoprotein-1.





























identity to three different MCPH genes – MCPH1,
MCPH3, and MCPH5 – and the ZIKV genome, again,
pointing to a possible role in neurodevelopment. In
addition, hsa-miR-4646 showed 100% identity for
MCPH2, hsa-miR-4528 with MCPH7, hsa-miR-3198
with MCPH11, and the ZIKV genome [19–21]. The
locations of each of the miRNAs to ZIKV and each of
the MCPH is illustrated in Figure 1.
We have particularly focused on the potential
role of miR-1304 that showed 100% identities to six
different MCPH genes. Of note, miR-1304 appears to
be initiated by the viral envelop gene (E). ZIKV has
two non-coding regions and a long reading frame
encoding a polyprotein that is cleaved by host cell
proteases to release the capsid protein C, the pre-
cursor of membrane (prM) and envelope E protein
and 7 non-structural proteins (NS1 to NS7, Figure 1).
The ZIKV virions contain 180 copies of protein E,
unknown amounts of other proteins, and a single
molecule of viral RNA [16]. The surface of the virions
is formed by E and M proteins. The E protein, which
is ∼53 kDa, is glycosylated. Since the E protein is the
main viral antigenic determinant, with membrane
binding and fusion capacity when the virus enters
the infected cell, any modulation by miR-1304 would
be an important factor to investigate [16,32]. Upon
release of viral RNA into the cytoplasm of infected
cells, it is replicated and translated by the cellular
machinery, leading to the formation of new viral
particles.
Neurodevelopment is a complex, dynamic process
that involves a precisely orchestrated sequence of
genetic, environmental, biochemical, and physical
events. A human brain contains approximately 120
billion neurons, of which 20% are located in the cere-
bral cortex [33]. Each cortical neuron has on average
7,000 synaptic connections to other neurons, resulting
in a total of 0.15 quadrillion synapses. This whole
sophisticated human brain system is caged into a
skull in which the brain floats in cerebrospinal fluid
with a volume of 1,350 cm3 and a total surface area of
1,820 cm2 [33]. Malformations of human fetal brain
can result due to interrupted cortical development,
and are common causes of mental disorders, includ-
ing developmental delay and epilepsy. However, the
clinical features are quite ambiguous: similar struc-
tural abnormalities can cause diverse symptoms. For
example, the same brain regions are affected by grey
matter loss in patients with different psychiatric con-
ditions (i.e. schizophrenia, major depression, and
addiction). The severity of cognitive abnormalities
scales with the degree of cortical dysplasia. This sug-
gests that brain function is closely correlated to brain
structure and that it is essential to understand how
and why structural abnormalities form. Several pathol-
ogies can originate from in utero viral infection that
may disrupt neurodevelopment [34].
Microcephaly is a rare developmental disorder
associated with an abnormally small brain. In micro-
cephalic brains, an altered cleavage plane during pro-
genitor cell division reduces vertical, symmetric cell
division and promotes horizontal, asymmetric cell
division. This reduces the overall number of progeni-
tor cells and neurons and decreases cortical volume.
In mild cases, the decrease in the total number of
neurons is not accompanied by a commensurate
loss of cortical folding. On the other hand, in more
severe cases, an additional increase of apoptosis
results in thinned cortices and abnormally small con-
volutions [33,34]. It is well documented that the
rubella virus (RV) induces microcephaly, where numer-
ous fetal progenitor cells are affected (reviewed in
[35]). Congenital Rubella Syndrome (CRS) generally
displays meningoencephalitis, retinopathy, cataract,
deafness, and various other non-neuropathic manifes-
tations [33]. CRS was first described in 1938; however,
the explicit pathway leading to teratogenicity still
remains to be elucidated. Many of the steps leading
to CRS and the consequences of CRS are well docu-
mented, but exactly how the virus causes this dra-
matic effect has been the subject of much
speculation. Rubella virus entry, tropism, and recep-
tor-related research still remain inconclusive [35].
It is interesting to note that newborns from ZIKV-
infected mothers exhibit ocular abnormities, as well as
other conditions that overlap with the symptoms of
CRS, suggesting that, similar to RV, an early in utero
infection may be the major reason for its neuropathic
effects and after, perhaps, late second trimester and
early third trimester the fetus may be safe from ZIKV-
induced neuropathy [12–14],
Lopez-Valenzuela et al. [36] have carried out an
extensive analyses of miRNA-1304 and shown that
the predicted targets for derived miR-1304 indicates
an association with behaviour and nervous system
development and function. Most importantly, they
identified various genes that miR-1304 targeted,
including 24 gene disorders, 14 neurological diseases,
as well as nervous system development and 13 func-
tion genes (reviewed in [36]).
miRNA-1304 has also been intimately connected
with vacuole structure and function through links
with VPS52, and the clathrin heavy chain (CLTC).
However, more intriguing, in context with the present
research is miRNA-1304’s potential to regulate expres-
sion of various genes that influence neurogenesis. It is
presently believed that miRNAs orchestrate the epi-
genetic regulation of neural stem cells and differentia-
tion of lineage populations of neurons,
oligodendrocytes, and other brain cells [34]. Down-
regulation of SOX5, a transcription factor that regu-
lates oligodendrogenesis and the sequential genera-
tion of cortical neurons (reviewed in [36]), may be
strongly influenced by miRNA-1304. Other pathologies





























connected with SOX5 deficiency include developmen-
tal and speech delay, and a rare 12p.12.1 microdele-
tion syndrome that is characterized by microcephaly.
miRNA-1304 has also been associated with CAPRIN2,
which engages in the expression of proteins involved
in synaptic plasticity in neurons. CAPRIN2 has positive
activation, stimulation, and up-regulation during den-
drite morphogenesis.
From extensive analyses, it is suggested that miR-
1304 is a relatively novel primate-specific miRNA. This
miRNA has been shown to express at very low levels
in human embryonic stem cells and after differentia-
tion of these cells into embryonic bodies [6]. The deep
RNA sequencing studies have uncovered low expres-
sion of miR-1304, in diverse tissues such as peripheral
blood, melanoma, and most importantly in brain cor-
tex [36]. The in silico approach, based on target site
predictions performed in this work, has allowed us to
gain insights into the putative role of miR-1304 in
development of microcephaly.
Interestingly, the analysis performed by Lopez-
Valenzuela et al. [36] using the Ingenuity software
associated the predicted targets of derived miR-1304
with biological processes and disorders related to
central nervous system development and function,
which suggests that the evolutionary change of miR-
1304 may affect aspects of human brain functioning
and cognition, establishing a foundation that miR-
1304 appear to play important function in neurodeve-
lopment, particularly of human brain cortex.
The main basis of miRNA action is its sequence
complementarity with the target regions of the
genes that they regulate, particularly at the seed
sequence. Functional SNPs that create or disrupt
these miRNA target sites have been shown to have
diverse phenotypic implications, perhaps contributing
toward microcephaly, among other human diseases
[32]. Since one miRNA can have multiple targets, a
precise identity between the seed sequence and the
target gene(s) would be expected to deliver a biolo-
gical effect that may disturb the expected gene func-
tion. So far, very few functional variants in miRNA
genes have been described, and only a small number
of studies have been devoted to describing their
functional consequences [25,32].
Functional roles and targets of miR-627–5, miR-4646,
miR-6771, miR-4528, miR-3198 have not been elucidated.
However, there is one report that has shown miR-627
mediates the epigenetic mechanisms of vitamin D to
suppress proliferation of human colorectal cancer cells
in vitro and growth of xenograft tumors in mice [37]. We
propose that these miRNAs have certain roles in neuro-
genesis or in development of microcephaly and may be
inhibited by ZIKV infection. It is also possible that some of
these miRNAs may be dysregulated indirectly due to
ZIKV-induced modulations of miRNAs that have been
reported by others in the case of Flaviviral infection [37].
Disclosure statement
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